JFA
RDY icon

JNBA Financial Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

JNBA Financial Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,995
Closed -$28K – 1133
2016
Q3 		$28K Buy
+2,995
New +$28.6K ﹤0.01% 705

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

JNBA Financial Advisors's RDY Position: Q4 2016 in Review

JNBA Financial Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q4 2016, closing a stake of 2,995 shares — an estimated $28K sold.

JNBA Financial Advisors first reported a position in RDY in Q3 2016 and held it in 1 quarter. The position peaked at $28K in Q3 2016. 164 funds tracked by Wall St. Rank hold RDY as of Q4 2016.

  • JNBA Financial Advisors reported no remaining Dr. Reddy's Laboratories position as of Q4 2016 after selling out during the quarter.
  • JNBA Financial Advisors sold 2,995 Dr. Reddy's Laboratories shares in Q4 2016, an estimated $28K.
  • JNBA Financial Advisors first reported a position in Dr. Reddy's Laboratories in Q3 2016 and held it in 1 quarter.
  • JNBA Financial Advisors's Dr. Reddy's Laboratories position peaked at $28K in Q3 2016.
  • 164 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2016.

Based on JNBA Financial Advisors's 13F filing for Q4 2016, filed 3 Feb 2017.